Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Radojewski

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Neuro-Oncology Advances|March 6, 2023
Accurate prediction of isocitrate dehydrogenase -mutation status of gliomas using SLOW-editing magnetic resonance spectroscopic imaging at 7 T MRGuodong Weng, Ekin Ermiş, Theoni Maragkou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trialNicolas Marincek, Piotr Radojewski, Rebecca A Dumont, et al.
Clinical Neuroradiology|March 31, 2023
Diagnosis of Small Unruptured Intracranial Aneurysms : Comparison of 7 T versus 3 T MRIPiotr Radojewski, Tomas Dobrocky, Mattia Branca, et al.
Human Brain Mapping|June 8, 2026
Mitigating the Impact of MR Sequence Parameters: Increasing the Robustness of DL-Based Cortical Thickness EstimatesTimo Blattner, David Romascano, Richard McKinley, et al.
Annals of Nuclear Medicine|December 22, 2020
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with <sup>177</sup>Lu-labeled prostate-specific membrane antigenKai Huang, Imke Schatka, Julian M M Rogasch, et al.
Human Brain Mapping|October 17, 2022
Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosisMichael Rebsamen, Richard McKinley, Piotr Radojewski, et al.
European Journal of Neurology|December 16, 2024
Assessment of the available evidence for the use of 7-Tesla (T) magnetic resonance imaging (MRI) in neurological and musculoskeletal disorders, with comparison to 3-T and 1.5-T MRI: A systematic scoping reviewPiotr Radojewski, Gian Franco Piredda, Gabriele Bonanno, et al.
European Journal of Neurology|November 28, 2022
Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literatureAnina Schwarzwald, Anke Salmen, Alejandro Xavier León Betancourt, et al.
Therapeutische Umschau. Revue Therapeutique|July 22, 2021
[Intracerebral haemorrhage - acute event and chronic disease]Martina Göldlin, Piotr Radojewski, Bernhard Siepen, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 28, 2015
Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinomaRebecca A Dumont, Daniela Seiler, Nicolas Marincek, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Neuro-Oncology Advances|March 6, 2023
Accurate prediction of isocitrate dehydrogenase -mutation status of gliomas using SLOW-editing magnetic resonance spectroscopic imaging at 7 T MRGuodong Weng, Ekin Ermiş, Theoni Maragkou, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trialNicolas Marincek, Piotr Radojewski, Rebecca A Dumont, et al.
Clinical Neuroradiology|March 31, 2023
Diagnosis of Small Unruptured Intracranial Aneurysms : Comparison of 7 T versus 3 T MRIPiotr Radojewski, Tomas Dobrocky, Mattia Branca, et al.
Human Brain Mapping|June 8, 2026
Mitigating the Impact of MR Sequence Parameters: Increasing the Robustness of DL-Based Cortical Thickness EstimatesTimo Blattner, David Romascano, Richard McKinley, et al.
Annals of Nuclear Medicine|December 22, 2020
Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with <sup>177</sup>Lu-labeled prostate-specific membrane antigenKai Huang, Imke Schatka, Julian M M Rogasch, et al.
Human Brain Mapping|October 17, 2022
Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosisMichael Rebsamen, Richard McKinley, Piotr Radojewski, et al.
European Journal of Neurology|December 16, 2024
Assessment of the available evidence for the use of 7-Tesla (T) magnetic resonance imaging (MRI) in neurological and musculoskeletal disorders, with comparison to 3-T and 1.5-T MRI: A systematic scoping reviewPiotr Radojewski, Gian Franco Piredda, Gabriele Bonanno, et al.
European Journal of Neurology|November 28, 2022
Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literatureAnina Schwarzwald, Anke Salmen, Alejandro Xavier León Betancourt, et al.
Therapeutische Umschau. Revue Therapeutique|July 22, 2021
[Intracerebral haemorrhage - acute event and chronic disease]Martina Göldlin, Piotr Radojewski, Bernhard Siepen, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 28, 2015
Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinomaRebecca A Dumont, Daniela Seiler, Nicolas Marincek, et al.
Pageof 6